Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase enzymes: regulation and function.

F A Fitzpatrick1

  • 1Department of Oncological Sciences & Department of Medicinal Chemistry, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah 84112-0555, USA. frank.fitzpatrick@hci.utah.edu

Current Pharmaceutical Design
|February 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of myeloperoxidase on colon tumor occurrence in inflamed versus non-inflamed colons of Apc(Min/+) mice.

Redox biology·2015
Same author

Stream Sediment Sources in Midwest Agricultural Basins with Land Retirement along Channel.

Journal of environmental quality·2015
Same author

Genesis and "suicide" of eicosanoid biosynthetic enzymes.

Trends in cardiovascular medicine·2011
Same author

Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function.

The Journal of biological chemistry·2010
Same author

Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.

Cancer prevention research (Philadelphia, Pa.)·2009
Same author

Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor.

Oncogene·2007
Same journal

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical design·2026
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
See all related articles

Cyclooxygenase (COX) enzymes produce prostaglandins, crucial for various bodily processes. Inhibiting COX with drugs like aspirin offers relief from inflammation and other conditions, with ongoing research for safer, more effective treatments.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Enzymology

Background:

  • Cyclooxygenase (COX) isoenzymes, COX-1 and COX-2, are key enzymes in synthesizing prostaglandins, thromboxane, and levuloglandins.
  • Prostaglandins mediate diverse physiological and pathological processes through G-protein coupled receptors, while levuloglandins exert effects via irreversible protein modification.
  • COX enzymes are targets for non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, used to treat inflammatory, pyretic, thrombotic, neurodegenerative, and oncological conditions.

Purpose of the Study:

  • To review the integrated catalytic mechanisms of COX enzymes, including their peroxidase and prostaglandin synthase activities.
  • To discuss the constitutive and pharmacological significance of irreversible COX inactivation.
  • To explore how cellular mechanisms differentiate the roles of COX-1 and COX-2 and how this knowledge informs drug development.

Related Experiment Videos

Main Methods:

  • Literature review of COX enzyme structure, function, and regulation.
  • Analysis of the historical development of NSAIDs and COX-2 selective inhibitors.
  • Examination of research on the therapeutic applications of COX inhibition.

Main Results:

  • COX enzymes possess dual catalytic functions (peroxidase and prostaglandin synthase) that operate in concert.
  • Irreversible COX inactivation is critical for both normal cellular function and therapeutic effects.
  • Distinct cellular roles of COX-1 and COX-2 have been elucidated, guiding the development of targeted therapies.
  • Advances in understanding COX enzymes have led to the repurposing of aspirin and the creation of novel anti-inflammatory and anti-cancer agents.

Conclusions:

  • Understanding COX enzyme mechanisms is vital for developing effective treatments for a range of diseases.
  • Targeted inhibition of COX isoenzymes offers therapeutic benefits with potentially reduced side effects.
  • Ongoing research continues to leverage knowledge of COX enzymes for novel drug discovery and application.